The prognostic importance of VEGF-A, PDGF-BB and c-MET in patients with metastatic colorectal cancer.

Mevlude InancHatice Aslan SirakayaHatice KaramanOktay Bozkurt

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)

The results of this research revealed a high c-Met expression relationship with worse PFS and low VEGF-A expression associated with poor metastatic overall survival in patients with metastatic colorectal cancer receiving bevacizumab therapies.

Keyphrases

metastatic colorectal cancer
poor prognosis
vascular endothelial growth factor
endothelial cells
squamous cell carcinoma
tyrosine kinase
small cell lung cancer
free survival
angiotensin ii
recombinant human